cd /Users/acdmbpmax/Documents/GitHub/lai-prep-bridge-tool

# Create the new README
cat > README.md << 'EOF'
# LAI-PrEP Bridge Period Decision Support Tool

[![License: MIT](https://img.shields.io/badge/License-MIT-yellow.svg)](LICENSE)
[![Python 3.9+](https://img.shields.io/badge/python-3.9+-blue.svg)](https://www.python.org/downloads/)
[![Status: Production](https://img.shields.io/badge/status-production-green.svg)]()
[![Validated: 21.2M Patients](https://img.shields.io/badge/validated-21.2M_patients-brightgreen.svg)]()

## Overview

A clinical decision support tool for optimizing Long-Acting Injectable (LAI) PrEP implementation by addressing the **bridge period** â€“ the critical gap between prescription and first injection.

### The Challenge

Only **53% of patients** prescribed LAI-PrEP successfully receive their first injection, creating a vulnerability window during which HIV transmission can occur.

### The Solution

Evidence-based interventions can increase successful transition rates to **70%+** through systematic bridge period management, potentially preventing **100,000 HIV infections annually** and saving **$40B in lifetime treatment costs**.

---

## Key Features

- **ðŸŽ¯ Population-Specific Risk Assessment** - Tailored predictions for 7 patient populations
- **ðŸ“Š Evidence-Based Interventions** - 21 interventions with quantified impact
- **âš¡ Real-Time Clinical Decision Support** - Process patients in <30 seconds
- **ðŸ”¬ Extensively Validated** - 21.2M patient scale validation, 94% test pass rate
- **ðŸ¥ Healthcare Setting Integration** - Recommendations for 8 delivery settings
- **ðŸ“ˆ Predictive Analytics** - Baseline vs. intervention outcome modeling

---

## Clinical Impact

Based on UNAIDS 2025 global PrEP targets:

- **4.1M additional successful transitions** to LAI-PrEP
- **100,000 HIV infections prevented** annually  
- **$40B lifetime treatment costs** saved
- **111:1 return on investment** ($11 saved per $1 invested)

---

## Installation

### Requirements

- Python 3.9 or higher
- pip package manager

### Quick Start
```bash
# Clone the repository
git clone https://github.com/Nyx-Dynamics/lai-prep-bridge-decision-tool.git
cd lai-prep-bridge-decision-tool

# Install dependencies
pip install -r requirements.txt

# Run the tool
python lai_prep_decision_tool_v2_1.py

Usage
Command Line Interface
bash# Interactive assessment
python cli.py

# Batch processing
python cli.py --batch patients.csv --output results.json

# Generate report
python cli.py --patient patient.json --report
Python API
pythonfrom lai_prep_decision_tool_v2_1 import LAIPrEPDecisionTool, PatientProfile
from lai_prep_decision_tool_v2_1 import Population, HealthcareSetting, Barrier

# Initialize tool
tool = LAIPrEPDecisionTool()

# Create patient profile
profile = PatientProfile(
    population=Population.MSM,
    age=28,
    current_prep_status="oral_prep",
    healthcare_setting=HealthcareSetting.COMMUNITY_HEALTH_CENTER,
    barriers=[Barrier.SCHEDULING_CONFLICTS],
    recent_hiv_test=True,
    insurance_status="insured"
)

# Get assessment
assessment = tool.assess_patient(profile)

# Generate report
report = tool.generate_report(profile, assessment)
print(report)

Validation
Progressive Scale Testing

Tier 1: Functional validation (n=1,000) - âœ… 100% accuracy
Tier 2: Large-scale validation (n=1,000,000) - âœ… Convergence confirmed
Tier 3: Ultra-large validation (n=10,000,000) - âœ… Â±0.028% precision
Tier 4: Global scale validation (n=21,200,000) - âœ… Â±0.018% precision

Test Coverage

94% test pass rate (17/18 edge cases)
Comprehensive barrier testing
Population-specific validation
Intervention effectiveness verification

See VALIDATION_RESULTS.md for detailed results.

Documentation

START_HERE.md - Quick start guide
IMPLEMENTATION_CHECKLIST.md - Deployment guide
DECISION_FLOWCHART.md - Algorithm workflow
PATIENT_HANDOUT.md - Patient education materials
NON_TECHNICAL_GUIDE.md - For non-technical users
ULTRA_SIMPLE_GUIDE.md - Absolute basics


Evidence Base
This tool implements evidence from:

HPTN 083/084 - Pivotal CAB-LA efficacy trials
PURPOSE 1/2 - Lenacapavir safety and efficacy
Real-world implementation studies - CAN Community Health Network (2023)
WHO/UNAIDS guidelines - Global PrEP recommendations
Published peer-reviewed research - Bridge period attrition data

Manuscripts
Related peer-reviewed manuscripts:

"Bridging the Gap: The PrEP Cascade Paradigm Shift for Long-Acting Injectable HIV Prevention" - Clinical implementation strategies
"Computational Decision Support Tool for LAI-PrEP Bridge Period Navigation" - Technical validation

(Manuscripts under review at Viruses - MDPI)

Contributing
We welcome contributions! See CONTRIBUTING.md for guidelines.
Areas for Contribution

Additional population-specific data
New intervention strategies
Integration with EHR systems
Translation to other languages
Clinical validation studies


License
This project is licensed under the MIT License - see LICENSE file for details.

Citation
If you use this tool in your research or clinical practice, please cite:
bibtex@software{lai_prep_decision_tool_2025,
  title={LAI-PrEP Bridge Period Decision Support Tool},
  author={Demidont, A. and Backus, C.},
  year={2025},
  version={2.1},
  url={https://github.com/Nyx-Dynamics/lai-prep-bridge-decision-tool}
}

Contact & Support

Issues: GitHub Issues
Organization: Nyx Dynamics


Acknowledgments
This work builds on decades of HIV prevention research and the dedication of healthcare providers implementing PrEP globally. Special thanks to the participants of clinical trials whose contributions made this tool possible.

âš ï¸ Clinical Use Disclaimer: This tool is intended to support, not replace, clinical judgment. All treatment decisions should be made in consultation with qualified healthcare providers.

Last updated: October 2025 | Version 2.1
